329 related articles for article (PubMed ID: 34747516)
21. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial.
Pérez-Castrillón JL; Dueñas-Laita A; Gómez-Alonso C; Jódar E; Del Pino-Montes J; Brandi ML; Cereto Castro F; Quesada-Gómez JM; Gallego López L; Olmos Martínez JM; Alhambra Expósito MR; Galarraga B; González-Macías J; Neyro JL; Bouillon R; Hernández-Herrero G; Fernández-Hernando N; Chinchilla SP
J Bone Miner Res; 2023 Apr; 38(4):471-479. PubMed ID: 36661855
[TBL] [Abstract][Full Text] [Related]
22. A randomized controlled trial of vitamin D3 supplementation in African American women.
Aloia JF; Talwar SA; Pollack S; Yeh J
Arch Intern Med; 2005 Jul; 165(14):1618-23. PubMed ID: 16043680
[TBL] [Abstract][Full Text] [Related]
23. The effect of high-dose vitamin D on bone mineral density and bone turnover markers in postmenopausal women with low bone mass--a randomized controlled 1-year trial.
Grimnes G; Joakimsen R; Figenschau Y; Torjesen PA; Almås B; Jorde R
Osteoporos Int; 2012 Jan; 23(1):201-11. PubMed ID: 21909730
[TBL] [Abstract][Full Text] [Related]
24. VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome.
Thiem U; Heinze G; Segel R; Perkmann T; Kainberger F; Mühlbacher F; Hörl W; Borchhardt K
Trials; 2009 May; 10():36. PubMed ID: 19480654
[TBL] [Abstract][Full Text] [Related]
25. Effect of high-dose cholecalciferol (vitamin D
Rovner AJ; Stallings VA; Rutstein R; Schall JI; Leonard MB; Zemel BS
Osteoporos Int; 2017 Jan; 28(1):201-209. PubMed ID: 27837268
[TBL] [Abstract][Full Text] [Related]
26. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
27. [Vitamin D and its positive effect on the PTH/vitamin D/calcium-FGF23/klotho/phosphorus axis in kidney transplant recipients].
Balcázar-Hernández L; Manuel-Apolinar L; Vargas Ortega G; González-Virla B; Reza-Albarrán AA; Jiménez Martínez MDC; Martínez Ordaz JL; Mendoza-Zubieta V; Basurto L
Nutr Hosp; 2023 Apr; 40(2):428-435. PubMed ID: 36926938
[TBL] [Abstract][Full Text] [Related]
28. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
Molina P; Górriz JL; Molina MD; Peris A; Beltrán S; Kanter J; Escudero V; Romero R; Pallardó LM
Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
[TBL] [Abstract][Full Text] [Related]
29. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D treatment in primary hyperparathyroidism: a randomized placebo controlled trial.
Rolighed L; Rejnmark L; Sikjaer T; Heickendorff L; Vestergaard P; Mosekilde L; Christiansen P
J Clin Endocrinol Metab; 2014 Mar; 99(3):1072-80. PubMed ID: 24423366
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease.
Moe SM; Saifullah A; LaClair RE; Usman SA; Yu Z
Clin J Am Soc Nephrol; 2010 Feb; 5(2):299-306. PubMed ID: 20056760
[TBL] [Abstract][Full Text] [Related]
32. Low-dose cholecalciferol supplementation and dual vitamin D therapy in haemodialysis patients.
Dusilová-Sulková S; Šafránek R; Vávrová J; Horáček J; Pavlíková L; Palička V
Int Urol Nephrol; 2015 Jan; 47(1):169-76. PubMed ID: 25262147
[TBL] [Abstract][Full Text] [Related]
33. Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study.
Delanaye P; Weekers L; Warling X; Moonen M; Smelten N; Médart L; Krzesinski JM; Cavalier E
Nephrol Dial Transplant; 2013 Jul; 28(7):1779-86. PubMed ID: 23378417
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biomarker modifiers of vitamin D treatment response: the Multi-Ethnic Study of Atherosclerosis.
Hsu S; Prince DK; Williams K; Allen NB; Burke GL; Hoofnagle AN; Li X; Liu KJ; McClelland RL; Michos ED; Psaty BM; Shea SJ; Rice KM; Rotter JI; Siscovick D; Tracy RP; Watson KE; Kestenbaum BR; de Boer IH
Am J Clin Nutr; 2022 Mar; 115(3):914-924. PubMed ID: 34849546
[TBL] [Abstract][Full Text] [Related]
35. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL).
Kaste SC; Qi A; Smith K; Surprise H; Lovorn E; Boyett J; Ferry RJ; Relling MV; Shurtleff SA; Pui CH; Carbone L; Hudson MM; Ness KK
Pediatr Blood Cancer; 2014 May; 61(5):885-93. PubMed ID: 24395288
[TBL] [Abstract][Full Text] [Related]
36. Calcitriol treatment in patients with low vitamin D levels.
Tanakol R; Gül N; Üzüm AK; Aral F
Arch Osteoporos; 2018 Oct; 13(1):114. PubMed ID: 30353299
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D, parathyroid hormone, and bone mineral density status in kidney transplant recipients.
Savaj S; Ghods FJ
Iran J Kidney Dis; 2012 Jul; 6(4):295-9. PubMed ID: 22797100
[TBL] [Abstract][Full Text] [Related]
38. Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃.
Schoenmakers I; Francis RM; McColl E; Chadwick T; Goldberg GR; Harle C; Yarnall A; Wilkinson J; Parker J; Prentice A; Aspray T
Trials; 2013 Sep; 14():299. PubMed ID: 24041337
[TBL] [Abstract][Full Text] [Related]
39. The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients.
Battaglia Y; Bellasi A; Esposito P; Bortoluzzi A; Rotondi S; Andreucci M; Fiorini F; Russo D; Storari A
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189376
[TBL] [Abstract][Full Text] [Related]
40. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids.
Wissing KM; Broeders N; Moreno-Reyes R; Gervy C; Stallenberg B; Abramowicz D
Transplantation; 2005 Jan; 79(1):108-15. PubMed ID: 15714177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
